← back to search

S. Saks

Cornell University · US

Area of research

Genetics · Hematology

Research interest

Research interests include Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments, Myeloproliferative Neoplasms: Diagnosis and Treatment, and Eosinophilic Disorders and Syndromes.

h-index

18

citations

1,029

works

21

NIH funding

—

primary concept

—

email

✉ Find email ↗

Recent publications

Rusfertide, a Hepcidin Mimetic, for Control of Erythrocytosis in Polycythemia Vera

New England Journal of Medicine 2024cited by 42position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sarita Khanna · Protagonist Therapeutics (United States)1 papers (2024–2024)Ronald Hoffman · Moffitt Cancer Center1 papers (2024–2024)Yelena Ginzburg · Mount Sinai Health System1 papers (2024–2024)Aaron T. Gerds · Cleveland Clinic1 papers (2024–2024)Andrew Kuykendall · Moffitt Cancer Center1 papers (2024–2024)Jeanne Palmer · Mayo Clinic in Arizona1 papers (2024–2024)Frank H. Valone · Protagonist Therapeutics (United States)1 papers (2024–2024)Uttam Kumar Nath · Seema Dental College and Hospital1 papers (2024–2024)Kristen Pettit · Wayne State University1 papers (2024–2024)Marina Kremyanskaya · Michigan Center for Translational Pathology1 papers (2024–2024)Jason Gotlib · University of California, San Francisco1 papers (2024–2024)Abdulraheem Yacoub · The University of Kansas Cancer Center1 papers (2024–2024)Ellen K. Ritchie · Cornell University1 papers (2024–2024)Srđan Verstovšek · Karus Therapeutics (United Kingdom)1 papers (2024–2024)Naveen Pemmaraju · The University of Texas MD Anderson Cancer Center1 papers (2024–2024)Suneel Gupta · Protagonist Therapeutics (United States)1 papers (2024–2024)Nishit B. Modi · Protagonist Therapeutics (United States)1 papers (2024–2024)Arturo Molina · Protagonist Therapeutics (United States)1 papers (2024–2024)